Pharmaceutical industry in Romania
The pharmaceutical industry in Romania is prosperous, with an average revenue of 8.3 billion lei per year.[1] Value chain in the pharmaceutical industry has increased significantly in the last decade in all segments, contributing with over 1% to GDP (2010).[2] There are 22 plants of productions which receive subsidies from the state.[3] The largest Romanian drugmaker is Terapia S.A., based in Cluj-Napoca.[4][5] The biggest player in distribution of drugs, depending on turnover, is Mediplus.[6] The company is part of A&D Pharma group, founded in 1994, which also controls the network of pharmacies Sensiblu. The logistics network of Mediplus consists of 10 regional warehouses and a national logistics center.
Regulation
The National Agency for Medicines and Medical Devices regulates the medicine and medical devices market. It supervises the manufacture, import and distribution of human-use medicines, investigates complaints about medicines and authorises and verifies clinical trials. Ministry of Health Order 194/2015 regulates the advertising of medicinal products. It prohibits gifts of more than €35 to clinicians.[7]
References
- ^ "Efectele crizei: sanatatea e subreda, industria farmaceutica prospera". Ziare.com. 3 January 2016.
- ^ "Industria farmaceutică din România: principalele tendințe și impactul asupra societății și economiei" (PDF). Institute for Economic Forecasting.
- ^ Ioana David (4 July 2012). "Harta producătorilor de medicamente din România: 22 de fabrici concentrate în nouă oraşe". Ziarul Financiar.
- ^ "Ranbaxy".
- ^ Sorin Alexandru (5 July 2015). "Topul celor mai mari producători de medicamente din România". Capital.
- ^ Raluca Abrihan (7 November 2014). "Topul celor mai mari jucători din piața românească de distribuție de medicamente". Forbes.
- ^ "Life Sciences: Compliance and enforcement in Romania". Lexology. 4 October 2018. Retrieved 4 February 2019.